Table 3.
Disease outcomes after retrieving 1–2 sentinel lymph nodes versus 3 or more nodes in patients with node-negative breast cancer at admission
| Variables | cN0 disease at admission | cN0 disease at admission after ALND exclusion | ||||||
|---|---|---|---|---|---|---|---|---|
| Total n = 68 |
1–2 SLN n = 15 |
≥ 3 SLN n = 53 |
p value | Total n = 58 |
1–2 SLN n = 13 |
≥ 3 SLN n = 45 |
p value | |
| Identification rate (n, %) | 62 (91.2%) | 13 (86.7%) | 49 (92.5%) | 0.397 | ||||
| Any recurrence (n, %) | 11 (16.2%) | 5 (33.3%) | 6 (11.3%) | 0.041 | 7 (12%) | 3 (23.1%) | 4 (8.9%) | 0.167 |
| In-breast/chest wall recurrence (n, %) | 2 (2.9%) | 0 | 2 (3.8%) | 0.605 | 2 (3.4%) | 0 | 2 (4.4%) | 0.439 |
| Axillary recurrence (n, %) | 2 (2.9%) | 2 (13.3%) | 0 | 0.046 | 2 (3.4%) | 2 (15.4%) | 0 | 0.007 |
| Distant recurrence (n, %) | 7 (10.3%) | 3 (20%) | 4 (7.5%) | 0.161 | 3 (5.1%) | 1 (7.7%) | 2 (4.4%) | 0.540 |
| Death (n, %) | 4 (5.9%) | 2 (13.3%) | 2 (3.8%) | 0.209 | 4 (6.8%) | 1 (7.7%) | 1 (2.2%) | 0.401 |
ALND Axillary lymph node dissection